>> Continued From the Previous Page <<
“Secretary Kennedy has made a leadership change within the Immediate Office of the Secretary,” an HHS spokesperson said in a statement. “Effective immediately, Matt Buckham will serve as Acting Chief of Staff.”
The announcement also praised Buckham for his background:
“Mr. Buckham currently serves as Kennedy’s White House liaison at the U.S. Department of Health and Human Services, where he oversees the recruitment and onboarding of political appointees across the agency. He brings valuable experience in personnel strategy and organizational management to this new role.”
The statement concluded with a nod to the outgoing staff:
“Secretary Kennedy thanks the outgoing leadership for their service and looks forward to working closely with Mr. Buckham as the Department continues advancing its mission to Make America Healthy Again.”
However, the timing of this reshuffling raised eyebrows. It came just days after the FDA—which falls under the HHS umbrella—gave full approval to Moderna’s Spikevax COVID-19 vaccine for children as young as six months old, specifically those considered “high-risk.”
Until recently, the shot was only available under Emergency Use Authorization (EUA). But on July 9th, the FDA gave full green light—despite ongoing concerns about side effects like myocarditis, allergic reactions, and seizures in young recipients.
The kicker? Kennedy reportedly had no knowledge of the decision before it was made public. The move blindsided his office.
Even more troubling is the man reportedly behind the surprise approval: Dr. Vinay Prasad, then-director of the FDA’s Center for Biologics Evaluation and Research (CBER). According to Grok AI, it was Prasad who pushed Spikevax across the finish line—with virtually no notice to HHS leadership.
“Vinay Prasad, as director of the FDA’s Center for Biologics Evaluation and Research, approved Moderna’s Spikevax COVID-19 vaccine for children aged 6 months to 11 years, but only for those with at least one underlying condition that puts them at high risk for severe COVID-19 outcomes,” the outlet reported.
Adding fuel to the fire, investigative journalist Laura Loomer dug into Prasad’s political leanings—calling out his alleged left-wing activism. Within days of her bombshell reporting, Prasad stepped down from his position at the FDA.
This stunning sequence of events reveals just how deep the swamp still runs, even under the leadership of someone like RFK Jr., who has publicly questioned the safety of the COVID vaccine rollout.
With Melanson’s departure, questions continue to swirl: Was her resignation tied to vaccine-related decisions made behind closed doors? And how much authority does Kennedy really wield over rogue bureaucrats inside HHS and the FDA?
One thing is certain—Americans deserve transparency, especially when it comes to injecting experimental pharmaceuticals into the arms of their children. The real scandal isn’t that Kennedy shuffled his staff. It’s that life-altering decisions about vaccines are still being made in the shadows, without proper oversight or accountability.
And once again, the mainstream media got the story dead wrong.
